---
layout: post
title: "Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV"
date: 2026-02-05 18:59:36 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-13538
original_published: 2022-06-24 00:00:00 +0000
significance: 8.00
---

# Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** June 24, 2022 00:00 UTC
**Document Number:** 2022-13538

## Summary

This final rule adopts, without change, an interim final rule with request for comments published in the Federal Register on May 7, 2021, placing serdexmethylphenidate, including its salts, isomers, and salts of isomers, in schedule IV of the Controlled Substances Act.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/06/24/2022-13538/schedules-of-controlled-substances-placement-of-serdexmethylphenidate-in-schedule-iv)
- API: https://www.federalregister.gov/api/v1/documents/2022-13538

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
